Home | Member Login | Join/Renew | Jobs | Contact
October 5, 2018, Healio
Most women who received an injection of brexanolone — a positive allosteric modulator of -aminobutyric-acid type A receptors — for postpartum depression had significant and clinically meaningful reductions of the condition at 60 hours vs. placebo, according to findings recently published in The Lancet.
Read more.
563 Carter Court, Suite B, Kimberly, WI 54136920-560-5620 / 800-545-0636920-882-3655 (fax)Email: APAOG@badgerbay.co
Quick Links
About APAOGContact UsJoin as a Member